184 related articles for article (PubMed ID: 20827222)
1. Magnetic resonance imaging of hypertrophic cardiomyopathy.
Cannavale A; Ordovás KG; Higgins CB
J Thorac Imaging; 2013 Jan; 28(1):W12-8. PubMed ID: 20827222
[TBL] [Abstract][Full Text] [Related]
2. MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances.
Hansen MW; Merchant N
AJR Am J Roentgenol; 2007 Dec; 189(6):1344-52. PubMed ID: 18029870
[TBL] [Abstract][Full Text] [Related]
3. MRI of hypertrophic cardiomyopathy: part I, MRI appearances.
Hansen MW; Merchant N
AJR Am J Roentgenol; 2007 Dec; 189(6):1335-43. PubMed ID: 18029869
[TBL] [Abstract][Full Text] [Related]
4. Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy.
Amado LC; Lima JA
Curr Opin Cardiol; 2010 May; 25(3):276-81. PubMed ID: 20224393
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic cardiomyopathy with restrictive phenotype and myocardial crypts.
Cannavale A; Ordovás KG; Rame EJ; Higgins CB
J Thorac Imaging; 2010 Nov; 25(4):W121-3. PubMed ID: 20463612
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic cardiomyopathy: assessment with MR imaging and multidetector CT.
Chun EJ; Choi SI; Jin KN; Kwag HJ; Kim YJ; Choi BW; Lee W; Park JH
Radiographics; 2010 Sep; 30(5):1309-28. PubMed ID: 20833852
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging for hypertrophic cardiomyopathy update.
Chan AK; Somarouthu B; Ghoshhajra B
Top Magn Reson Imaging; 2014 Feb; 23(1):33-41. PubMed ID: 24509622
[TBL] [Abstract][Full Text] [Related]
8. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.
Bogaert J; Olivotto I
Radiology; 2014 Nov; 273(2):329-48. PubMed ID: 25340269
[TBL] [Abstract][Full Text] [Related]
9. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
[TBL] [Abstract][Full Text] [Related]
10. Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonance.
Ghio S; Revera M; Mori F; Klersy C; Raisaro A; Raineri C; Serio A; Pasotti M; Visconti LO
Eur J Heart Fail; 2009 Oct; 11(10):952-7. PubMed ID: 19789398
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure.
Yoshida A; Ishibashi-Ueda H; Yamada N; Kanzaki H; Hasegawa T; Takahama H; Amaki M; Asakura M; Kitakaze M
Eur J Heart Fail; 2013 Feb; 15(2):166-75. PubMed ID: 23329703
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
[TBL] [Abstract][Full Text] [Related]
14. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
Maron MS
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172
[TBL] [Abstract][Full Text] [Related]
15. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances.
Amano Y; Takayama M; Takahama K; Kumazaki T
J Magn Reson Imaging; 2004 Oct; 20(4):595-600. PubMed ID: 15390225
[TBL] [Abstract][Full Text] [Related]
16. Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy (HCM): but what about 'apical' HCM?
Dastidar AG; Rodrigues J; Bucciarelli-Ducci C
Heart; 2014 Dec; 100(23):1898. PubMed ID: 25248754
[No Abstract] [Full Text] [Related]
17. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
Nojiri A; Hongo K; Kawai M; Komukai K; Sakuma T; Taniguchi I; Yoshimura M
J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327
[TBL] [Abstract][Full Text] [Related]
18. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
[TBL] [Abstract][Full Text] [Related]
19. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
Teraoka K
Magn Reson Imaging; 2005 Jun; 23(5):701. PubMed ID: 16051047
[No Abstract] [Full Text] [Related]
20. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
Dimitrow PP
Magn Reson Imaging; 2004 Nov; 22(9):1339. PubMed ID: 15607110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
